We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

237 hedge funds and large institutions have $3.87B invested in Arena Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 82 increasing their positions, 71 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $30.5M | Put options by funds: $14.7M

15% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 71

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

1% more funds holding

Funds holding: 235 → 237 (+2)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

1% less capital invested

Capital invested by funds: $3.89B → $3.87B (-$22.7M)

Holders
237
Holders Change
+2
Holders Change %
+0.85%
% of All Funds
4.13%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
38
Increased
82
Reduced
71
Closed
35
Calls
$30.5M
Puts
$14.7M
Net Calls
+$15.7M
Net Calls Change
+$4.31M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$57.4M
2
WP
Woodline Partners
California
+$27.4M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$24.4M
4
Holocene Advisors
Holocene Advisors
New York
+$24.2M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$23.5M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$57M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$46.6M
3
PA
Perceptive Advisors
New York
-$39.9M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$27.4M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$19.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAM
101
Advisors Asset Management
Colorado
$2.01M -$123K -1,882 -6%
Tudor Investment Corp
102
Tudor Investment Corp
Connecticut
$1.96M +$1.87M +28,684 New
DekaBank Deutsche Girozentrale
103
DekaBank Deutsche Girozentrale
Germany
$1.87M – – –
AQR Capital Management
104
AQR Capital Management
Connecticut
$1.86M – – –
ProShare Advisors
105
ProShare Advisors
Maryland
$1.83M +$188K +2,891 +12%
EAM
106
Erste Asset Management
Austria
$1.8M – – –
State Board of Administration of Florida Retirement System
107
State Board of Administration of Florida Retirement System
Florida
$1.69M +$77.1K +1,183 +5%
WG
108
Winton Group
United Kingdom
$1.68M +$283K +4,338 +21%
CAM
109
Connacht Asset Management
New York
$1.57M -$786K -12,050 -34%
MIM
110
MetLife Investment Management
New Jersey
$1.56M – – –
Squarepoint
111
Squarepoint
New York
$1.53M +$1.05M +16,104 +255%
AIM
112
Artemis Investment Management
United Kingdom
$1.52M +$1.45M +22,231 New
BC
113
Birchview Capital
Vermont
$1.5M – – –
HighTower Advisors
114
HighTower Advisors
Illinois
$1.49M -$34.9K -535 -2%
SCM
115
Sio Capital Management
New York
$1.48M – – –
ACM
116
AlphaCrest Capital Management
New York
$1.45M +$485K +7,442 +54%
Principal Financial Group
117
Principal Financial Group
Iowa
$1.45M +$114K +1,751 +9%
Royal Bank of Canada
118
Royal Bank of Canada
Ontario, Canada
$1.44M -$348K -5,333 -20%
IBT
119
International Biotechnology Trust
United Kingdom
$1.43M – – –
CIP
120
Chartwell Investment Partners
Pennsylvania
$1.34M +$12.2K +187 +1%
CIM
121
Cambria Investment Management
California
$1.18M +$110K +1,692 +11%
Prudential Financial
122
Prudential Financial
New Jersey
$1.17M +$783K +12,010 +231%
Jacobs Levy Equity Management
123
Jacobs Levy Equity Management
New Jersey
$1.17M +$1.12M +17,171 New
SFI
124
Susquehanna Fundamental Investments
Pennsylvania
$1.16M +$585K +8,970 +112%
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$1.15M +$68.9K +1,057 +7%
3 4
5
6 7

ARNA Hedge Fund Activity: Q2 2021 in Review

237 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2021, worth a combined $3.87B — down 0.58% from $3.89B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ARNA positions and 35 closed out — a net gain of 3 holders — while 82 added to existing stakes and 71 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $57.4M. The largest seller was AllianceBernstein, cutting an estimated $57M.

  • 237 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2021, up from 235 in Q1 2021.
  • Funds reported $3.87B of Arena Pharmaceuticals Inc stock for Q2 2021, down 0.58% quarter-over-quarter.
  • 38 funds opened new Arena Pharmaceuticals Inc positions in Q2 2021 and 35 closed out, a net change of +3 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2021 was JP Morgan Chase, an estimated $57.4M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2021 was AllianceBernstein, an estimated $57M sold.

Based on aggregated 13F filings for Q2 2021.